0.340
0.34 (0%)
As of Aug 28, 2023
Mallinckrodt Plc [MNK]
Source:
Company Overview
Mallinckrodt plc is a global business of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products.
Country | United States |
Headquarters | dublin 15 |
Phone Number | 353 1 6960000 |
Industry | manufacturing |
CEO | Sigurdur Olafsson |
Website | mallinckrodt.com |